Yamaguchi Hiroyuki, Osaki Takako, Taguchi Haruhiko, Sato Noriko, Toyoda Atushi, Takahashi Motomichi, Kai Masanori, Nakata Noboru, Komatsu Akio, Atomi Yutaka, Kamiya Shigeru
Department of Infectious Disease, Division of Medical Microbiology, Kyorin University School of Medicine, Mitaka-shi, Tokyo, Japan.
Clin Diagn Lab Immunol. 2003 Sep;10(5):808-12. doi: 10.1128/cdli.10.5.808-812.2003.
In order to assess the efficacy of oral Helicobacter pylori heat shock protein 60 (HSP60) as a vaccine, protection against H. pylori infection in specific-pathogen-free (SPF) C57BL/6 and germfree (GF) IQI mice was examined. Prophylactic oral vaccination of these two strains of mice with either H. pylori HSP60 or Escherichia coli GroEL inhibited H. pylori colonization by 90 to 95% at 3 weeks postinfection (p.i.). However, these mice were only partially protected because bacterial loads increased in all animals at 10 weeks p.i. Anti-H. pylori HSP60 immunoglobulin G was detected in serum at 3 weeks p.i. in mice vaccinated with either H. pylori HSP60 or GroEL. Significant increases in the gastritis scores were observed only in SPF mice immunized with H. pylori HSP60. These results indicate that oral vaccination with H. pylori HSP60 has partial protective effects on subsequent H. pylori infection but also induces postimmunization gastritis. However, GF mice immunized with H. pylori HSP60 did not suffer from severe gastritis. Therefore, the presence of bacterial flora appears to contribute to the induction of postimmunization gastritis.
为了评估口服幽门螺杆菌热休克蛋白60(HSP60)作为疫苗的效果,检测了无特定病原体(SPF)的C57BL/6小鼠和无菌(GF)的IQI小鼠对幽门螺杆菌感染的抵抗力。用幽门螺杆菌HSP60或大肠杆菌GroEL对这两种品系的小鼠进行预防性口服疫苗接种,在感染后3周时,幽门螺杆菌的定植被抑制了90%至95%。然而,这些小鼠只是部分受到保护,因为在感染后10周时所有动物体内的细菌载量都增加了。在感染后3周时,用幽门螺杆菌HSP60或GroEL接种的小鼠血清中检测到了抗幽门螺杆菌HSP60免疫球蛋白G。仅在接种幽门螺杆菌HSP60的SPF小鼠中观察到胃炎评分显著增加。这些结果表明,口服幽门螺杆菌HSP60疫苗对随后的幽门螺杆菌感染有部分保护作用,但也会引发免疫后胃炎。然而,用幽门螺杆菌HSP60免疫的GF小鼠并未患上严重胃炎。因此,细菌菌群的存在似乎有助于引发免疫后胃炎。